January 11, 2021 Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test read more
December 29, 2020 Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test read more
October 29, 2020 Quanterix Corporation To Release Third Quarter 2020 Financial Results On November 5, 2020 read more
October 6, 2020 Quanterix Receives National Institutes Of Health Radx Contract To Advance Antigen Test For Sars-cov-2 (Covid-19) read more
October 5, 2020 Quanterix Enters Into A License Agreement That Grants Abbott Access To Portfolio Of Bead-based Technology Patents For Use In In Vitro Diagnostics read more
September 10, 2020 Quanterix’ Simoa Technology Supports 42 Scientific Presentations At MSVirtual2020 read more